2009-2016

Based on needs assessment, the Stent for Life Initiative was launched by the coalition of the European Association of Percutaneous Cardiovascular Interventions (EAPCI), a registered branch of the European Society of Cardiology (ESC), and EuroPCR, at the EAPCI General Assembly, during the ESC Annual Congress in 2009, in Barcelona (5, 2).

The initial phase of this pan-European project was focused on the positive experience of five countries to provide the best practice examples (4). The Netherlands, the Czech Republic, Sweden, Denmark and Austria were visited and the logistics of ACS treatment was studied. Public campaigns improved patient access to acute PCI. Regional networks involving emergency medical services (EMS), non-PCI hospitals and PCI centres were useful in providing access to acute PCI for most patients. Direct transfer from the first medical contact site to the cathlab was found essential to minimise the time delays. Cathlab staff work had to be organised to provide acute PCI services 24 hours a day/seven days a week (24/7).

Even in those regions where thrombolysis was still used due to long transfer distances to PCI, patients had to be transferred to a PCI centre after thrombolysis. The highest risk non-ST elevation acute myocardial infarction patients were planned to undergo emergency coronary angiography within two hours of hospital admission, i.e. similar to STEMI patients.

Three realistic goals for other countries were defined based on these experiences:

1. primary PCI should be used for >70% of all STEMI patients,
2. primary PCI rates should reach >600 per million inhabitants per year and
3. existing PCI centres should treat all their STEMI patients by primary PCI, i.e. should offer 24/7 service.

Soon, 21 National Cardiac Societies and/or working groups or associations of Interventional Cardiology signed the obligation to take effective actions to fulfill the Stent for Life Initiative Mission in their country. Each of these SFL Member Countries implemented an action programme to increase patient access to p-PCI (3, 6).

In 2014, Kristensen et al. reported that a huge progress was made (1). Primary percutaneous coronary intervention was the dominant reperfusion strategy in 33 out of 37 countries. Nevertheless, still large variations in reperfusion treatment were present across Europe. Countries in Eastern and Southern Europe reported in particular that a substantial number of STEMI patients are not receiving any reperfusion therapy. The authors recommended strongly to further encourage the implementation of p-PCI as recommended in the guidelines.

At the end of 2016, the founders, PCR and EAPCI assessed the success of the last years and the future potential of the initiative. They found, that already then, Stent for Life had long grown beyond the borders of Europe. Countries like Egypt, Tunisia, South Africa, India, Sri Lanka, Argentina and Mexico joined and other countries expressed their strong interest and needs to become part of this initiative. So, without notice, Stent for Life had become global and the founders needed to think about how to adapt in order to be prepared for the challenges to come.

Since 2017, the Stent – Save a Life Initiative was founded as the global extension and continuation of Stent for Life. A new name denotes a new era, however, the mission remained unchanged:

“To improve the delivery of care and patient access to the lifesaving indication of primary percutaneous coronary intervention, thereby reducing mortality and morbidity in patients suffering from acute myocardial infarction.”

1. “Stent 4 Life” targeting PCI at all who will benefit the most. A joint project between EAPCI, Euro-PCR, EUCOMED and the ESC Working Group on Acute Cardiac Care.
   Widimsky P, Fajadet J, Danchin N, Wijns W.
   EuroIntervention. 2009 Mar;4(5):555, 557. PubMed PMID: 19378673.
2. European Association for Percutaneous Cardiovascular Interventions.. Reperfusion therapy for ST elevation acute myocardial infarction 2010/2011: current status in 37 ESC countries.
   Kristensen SD, Laut KG, Fajadet J, Kaifoszova Z, Kala P, Di Mario C, Wijns W, Clemmensen P, Agladze V, Antoniades L, Alhabib KF, De Boer MJ, Claeys MJ, Deleanu D, Dudek D, Erglis A, Gilard M, Goktekin O, Guagliumi G, Gudnason T, Hansen KW, Huber K, James S, Janota T, Jennings S, Kajander O, Kanakakis J, Karamfiloff KK, Kedev S, Kornowski R, Ludman PF, Merkely B, Milicic D, Najafov R, Nicolini FA, No? M, Ostojic M, Pereira H, Radovanovic D, Sabaté M, Sobhy M, Sokolov M, Studencan M, Terzic I, Wahler S, Widimsky P;
   Eur Heart J. 2014 Aug 1;35(29):1957-70. doi: 10.1093/eurheartj/eht529. Epub 2014 Jan 12. Erratum in: Eur Heart J. 2014 Oct 7;35(38):2697. PubMed PMID: 24419804.
3. Stent for Life: how this initiative began?
   Widimsky P, Wijns W, Kaifoszova Z.
   EuroIntervention. 2012 Aug;8 Suppl P:P8-10. doi: 10.4244/EIJV8SPA3. PubMed PMID: 22917797.
4. Stent for Life Initiative: where are we standing and where are we going?
   Widimsky P, Kristensen SD.
   Eur Heart J Acute Cardiovasc Care. 2012 Apr;1(1):48-9. doi: 10.1177/2048872612441584. PubMed PMID: 24062887; PubMed Central PMCID: PMC3760550.
5. How to set up an effective national primary angioplasty network: lessons learned from five European countries.
   Knot J, Widimsky P, Wijns W, Stenestrand U, Kristensen SD, Van’ T Hof A, Weidinger F, Janzon M, Nörgaard BL, Soerensen JT, van de Wetering H, Thygesen K, Bergsten PA, Digerfeldt C, Potgieter A, Tomer N, Fajadet J.
   EuroIntervention. 2009 Aug;5(3):299, 301-309. PubMed PMID: 19736153.
6. Implementation of primary angioplasty in Europe: stent for life initiative progress report.
   Kristensen SD, Fajadet J, Di Mario C, Kaifoszova Z, Laut KG, Deleanu D, Gilard M, Guagliumi G, Goktekin O, Jorgova J, Kanakakis J, Ostojic M, Pereira H, Sabate M, Sobhy M, Vrints C, Wijns W, Widimsky P.
   EuroIntervention. 2012 May 15;8(1):35-42. doi: 10.4244/EIJV8I1A7. PubMed PMID: 22580247.

Stent – Save a Life! is a joint initiative between three co-editors: Cardiovascular Solutions for Life, the European Association of Percutaneous Cardiovascular Interventions (EAPCI), a registered branch of the European Society of Cardiology (ESC) and PCR.

These General Terms and Conditions govern the use of the Stent – Save a Life! website (www.stentsavealife.com).

The Stent – Save a Life! website is owned by Cardiovascular Solutions for Life; its registered office is located at the address mentioned below. The web site is hosted in Germany. The Stent – Save a Life! website is in English, which is the official language for all external Stent – Save a Life! communications.

This web site is published by:

– Publishing director: C. Naber, Cardiovascular Solutions for Life

Cardiovascular Solutions for Life e.V., a non-profit association duly organised and existing under German law and having an office and principal place of business at

c/o Contilia GmbH
z.Hd. PD Dr. Christoph K. Naber
Huttropstr. 58
45138 Essen
Germany

• Web agency: Europa Digital & Publishing
• Website Hosting: 1&1 Internet AG

ONLINE SERVICE AGREEMENT

By using the Stent – Save a Life! website you agree to comply with these Terms and Conditions. Please read them carefully as they contain important legal information with regard to the Stent – Save a Life! website.  They imply rights and obligations from and to Stent – Save a Life!. When applicable, Stent – Save a Life! may complement these Terms & Conditions with specific Rules & Regulations posted at the product or service web location. In the event of any conflict or inconsistency the latter shall prevail.

Stent – Save a Life! reserves the right to amend these Terms & Conditions at its sole discretion, without prior notice, with the proviso that details of the amendments are published on the Stent – Save a Life! website.  They become effective from the time of posting. Your use of the Stent – Save a Life! website after the posting constitutes your acceptance to the modified Terms & Conditions.

Should you require further information or have comments on the Stent – Save a Life! website Terms & Conditions, please use the Contact Us form. 

Copyright – Intellectual Property

The Stent for Life Web site is owned by Cardiovascular Solutions for Life e.V. All content on the Stent – Save a Life! Web site is copyright under German and International law established by the Intellectual Property Code.

All content on the Stent – Save a Life! Web site (including without limitation all articles, statements, texts, images, logos and design) is copyright © 2017 Cardiovascular Solutions for Life e.V. All rights reserved.

Content from the Stent – Save a Life! Web site, and any corporate identity resources with the exception of the Stent – Save a Life! Logo*, may be copied and distributed on a limited basis for non-commercial purposes only, provided that any material copied remains intact and that all copies include the following notice in a clearly visible position: “Copyright © 2017 Cardiovascular Solutions for Life e.V. All rights reserved”. These materials are for personal use only.

*The Stent – Save a Life! Logo is a registered trademark and its use is protected under international copyright laws. Reproduction or use of the Stent – Save a Life! logo, without the prior written permission of Cardiovascular Solutions for Life e.V., is strictly prohibited.

To copy, modify or use the Stent – Save a Life! Web site or its contents for any commercial purpose without the authorisation of Cardiovascular Solutions for Life e.V. is a violation of patent, copyright and other proprietary rights including intellectual property rights owned by Cardiovascular Solutions for Life e.V. and/or its contributors. Any copying or redistribution for commercial purposes or for compensation of any kind requires prior written permission from Cardiovascular Solutions for Life e.V.

The use of Stent – Save a Life! corporate visuals (including, but not limited to, graphics, images, videos…) and Stent – Save a Life! corporate motto use is subject to written authorisation by Cardiovascular Solutions for Life e.V.

Any unapproved use may result in actions being taken by Cardiovascular Solutions for Life e.V. to require removal of material concerned from display/distribution and possible legal action. For any question on Intellectual Property, please use the Contact Us form.

Stent – Save a Life! Web Site General Conditions

Content, products and services

The Stent – Save a Life! Web site and all of its component elements, including text, graphics, images, hyperlinks and other materials supplied by Stent – Save a Life! contributors and/or third parties, is for general educational and informational purposes only and does not replace professional medical advice. Those seeking medical advice should always consult their physician or other medical professional.

Cardiovascular Solutions for Life e.V. cannot endorse all statements or opinions made on the Stent – Save a Life! Web site. Under no circumstances will Cardiovascular Solutions for Life e.V. be held liable for any decision taken or acted upon as a result of reliance on the content of the Stent – Save a Life! Web site. Please refer to the Disclaimer for complete information on this matter.

Cardiovascular Solutions for Life e.V. reserves the right to add, modify or remove any information, products and/or services from the Stent – Save a Life! Web site at any time and without notice.

Cardiovascular Solutions for Life e.V. disclaims any responsibility concerning the information and/or materials on sites hyperlinked from the Stent – Save a Life! Web site.

Policies

Hyperlinking Policies

– External hyperlinks from the Stent – Save a Life! Web site

The Stent – Save a Life! Web site hosts a number of links to external websites from www.stentsavealife.com. In providing these links, Cardiovascular Solutions for Life e.V. does not endorse the content, the products, services or viewpoints expressed by these external websites. The Stent – Save a Life! Web site Terms and Conditions no longer apply when you leave the Stent – Save a Life! Web site. The terms and conditions of the linked site then apply.

– Hyperlinking to the Stent – Save a Life! Web site

Hyperlinking is permitted under limited conditions.

Disclaimer

Cardiovascular Solutions for Life e.V. cannot endorse all statements or opinions made on the web site.

The component information of the Stent – Save a Life! Web site is not intended or implied to be a substitute for professional medical advice or medical care. The advice of a medical professional should always be sought prior to commencing any form of medical treatment. To this end, all component information contained within the web site is done so for solely educational purposes. Cardiovascular Solutions for Life e.V. and all of its staff, suppliers, agencies and members disclaim any and all warranties and representations with regards to the information contained on the Stent – Save a Life! Web site. This includes any implied warranties and conditions that may be derived from the aforementioned web site information.

Liability

Under no circumstances will Cardiovascular Solutions for Life e.V. or any affiliated staff or web site contributors, be liable to you, as a web site visitor or any other person or body, for any decision taken or acted upon as a result of reliance on the information or philosophies contained or expressed within the Stent – Save a Life! web site . You agree that neither Cardiovascular Solutions for Life e.V. nor any affiliated staff or web site contributors, will be responsible for any loss or damage (including, without limitation, direct, indirect, incidental, special or consequential damages), or loss of data or loss of profit, even if Cardiovascular Solutions for Life e.V. or any affiliated staff or web site contributors, has been advised of the possibility of such loss.

Indemnity

You irrevocably indemnify Cardiovascular Solutions for Life e.V. and its affiliated staff and web site contributors, from and against, any and all losses, damages and costs, suffered or incurred by the Cardiovascular Solutions for Life e.V. and its affiliated staff and web contributors, of whatsoever nature, arising out of or in connection with, your use, provision, or distribution of information or any part of the Stent – Save a Life! Web site component contents, that arise in relation to any breach of these Terms and Conditions by you.

Legal Jurisdiction and Applicable Law

Any disputes relating to the Stent – Save a Life! Web site or to these Terms & Conditions shall be brought before the court at Essen and will be governed and analysed according to German law, on their merits, independently of the rules concerning conflicting legislation.

Disclosure of information and Marketing

Cardiovascular Solutions for Life e.V. complies with EC directives, and takes all reasonable care to prevent any unauthorised access to your personal data. Cardiovascular Solutions for Life e.V. staff and contractors have a responsibility to keep your information confidential.

Cardiovascular Solutions for Life e.V. does not sell, trade, or rent your personal information to others and does not disclose personal information to any other person or organisation without your consent.

External Links

The Stent – Save a Life! Web site contains links to other websites. Please be aware that Cardiovascular Solutions for Life e.V. is not responsible for the privacy policies of other sites. You are therefore encouraged to read the privacy policies of any other site that collects personally identifiable information. This privacy policy applies solely to information collected by Cardiovascular Solutions for Life e.V.

Data Privacy Statement

In accordance with German lawou have the right to access, to oppose, to modify, to correct and to delete any personal data that you have provided to us. To exercise this right, write to the data processing manager at the following address:

Advertising and Sponsorship Policy

The stentsavealife.com website is a free service which is partially funded by unrestricted educational grants from industry partners.

Our editorial content is never influenced by the funding sources Any sponsored editorial content that is published on the website is always clearly marked as such, with the name of the sponsor clearly visible. Promoted editorial content is clearly marked as such and contains the indication “Promoted content” so as to ensure absolute transparency to all website visitors.

 Your Comments

If you any further questions about the Cardiovascular Solutions for Life e.V. Privacy and Security Policy or its implementation, or if at any time you believe that Cardiovascular Solutions for Life e.V. has not adhered to the principles stated in this Policy, please Contact Us.